Antioxidant capacity, antibacterial activity, and cell cytotoxicity in cholangiocarcinoma (CCA) from Boesenbergia rotunda (L.) Mansf.
Article Sidebar
Main Article Content
Abstract
Boesenbergia rotunda (L.) Mansf. rhizome was collected during different seasons and cultivation areas, defined as S1, S2, and S3. The rhizome extract was prepared by sequential maceration in hexane, ethyl acetate, and methanol. The rhizome extracts were evaluated for antioxidant, total phenolic and flavonoid content, cytotoxicity against cholangiocarcinoma (CCA), and pathogenic bacteria effects. The S2 extract in hexane and ethyl acetate demonstrated the highest Trolox Equivalent Antioxidant Capacity (TEAC) at 2.650 ± 0.215 and 2.089 ± 0.405, respectively. The highest total phenolic and flavonoid content were found in the S1 and S3 ethyl acetate extracts at 18.187 ± 0.961 mg- Gallic acid Equivalent (GE)/g-Dry Material (DM) and 381.863 ± 18.917 mg-Quercetin Equivalents (QE)/100 g-DM, respectively. The greatest cytotoxicity against CCA was found in the S2 ethyl acetate extract with an IC50 value of 22.65 ± 0.68 mg/mL, however, this did not affect normal cholangiocytes. Moreover, the cytotoxic effect on CCA may have involved apoptosis based on the chromatin condensation and nuclear fragment seen using fluorescence microscopy with 4′,6-diamidino-2-phenylindole staining. The S1 ethyl acetate extract was cytotoxic to gram-positive bacteria. The inhibition zone was 10.5, 9.5, 8.5, and 11.8 mm for Staphylococcus aureus ATCC 25923, Methicillin-resistant S. aureus (MRSA), S. epidermidis, and Bacillus cereus, respectively. In conclusion, this study demonstrated that there are active components in B. rotunda rhizome hexane and ethyl acetate extracts that have antioxidant, anticancer, and antibacterial activities. The active ingredients should be characterized in future studies.
Article Details
References
Ongwisespaiboon O, Jiraungkoorskul W. Fingerroot, boesenbergia rotunda and its aphrodisiac activity. Pharmacogn Rev. 2017;11(21):27-30.
Chong TE, Kee LY, Fei CC, Han HC, Ming WS, Ping TL, et.al. Boesenbergia rotunda: from ethnomedicine to drug discovery. Evid Based Complement Alternat Med. 2012(10):473637-473662.
Chuakul W, Boonpleng A. Ethnomedical uses of Thai zingiberaceous plant. J Med. 2006;10(1):33-39.
Salguero CP. A Thai herbal: traditional recipes for health and harmony. 1st ed. Forres; Findhorn Press: 2003.
Mahady GB, Bhamarapravati S, Adeniyi BA, Doyle B, Locklear T, Slover C, et.al. Traditional Thai medicines inhibit Helicobacter pylori in vitro and in vivo: support for ethnomedical use. Ethnobot Res Appl. 2006;4:159-165.
Riswan S, Roemantyo SH. Jamu as traditional medicine in Java, Indonesia. South Pacific Study. 2002;23(1):1-10.
Ching A, Wah T, Sukari M, Lian G, Rahmani M, Khalid K. Characterization of flavonoid derivatives from Boesenbergia rotunda (L.) Mansf. Malays J Anal Sci. 2007;11(1):154-159.
Morikawa T, Funakoshi K, Ninomiya K, Yasuda D, Miyagawa K, Matsuda H, et al. Medicinal foodstuffs. XXXIV. Structures of new prenylchalcones and prenylflavanones with TNF-alpha and aminopeptidase N inhibitory activities from Boesenbergia rotunda. Chem Pharm Bull. 2008;56(7):956-962.
Yusuf N, Annuar M, Khalid N. Existence of bioactive flavonoids in rhizomes and plant cell cultures of Boesenbergia rotunda (L.). Mansf. Kulturpfl. Aust J Crop Sci. 2013;7(6):730-34.
Baharudin MKA, Hamid SA, Susanti D. Chemical composition and antibacterial activity of essential oils from three aromatic plants of the Zingiberaceae family in Malaysia. J Phys Sci. 2015;26(1):71-81.
Jing LJ, Mohamed M, Rahmat A, Abu BM. Phytochemicals, antioxidant properties and anticancer investigations of the different parts of several gingers species (Boesenbergia rotunda, Boesenbergia pulchella var attenuata and Boesenbergia armeniaca). J Med Plants Res. 2010;4(1):27-32.
Atun S, Handayani S, Rakhmawati A. Potential bioactive compounds isolated from Boesenbergia rotunda as antioxidant and antimicrobial agent. Pharmacogn J. 2018 May-Jun;10(3):513-518.
Jitvaropas R, Saenthaweesuk S, Somparn N, Thuppia A, Sireeratawong S, Phoolcharoen W. Antioxidant, antimicrobial and wound healing activities of Boesenbergia rotunda. Nat Prod Commun. 2012;7(7):909-912.
Rukayadi Y, Shim JS, Hwang JK. Screening of Thai medicinal plants for anticandidal activity. Mycoses. 2008;51(4):308-312.
Abdelwahab SI, Mohan S, Abdulla MA, Sukari MA, Abdul AB, Taha MM, et.al. The methanolic extract of Boesenbergia rotunda (L.) Mansf. and its major compound pinostrobin induces anti-ulcerogenic property in vivo: possible involvement of indirect antioxidant action. J Ethnopharmacol. 2011 2;137(2):963-970.
Sawangjaroen N, Phongpaichit S, Subhadhirasakul S, Visutthi M, Srisuwan N, Thammapalerd N. The anti-amoebic activity of some medicinal plants used by AIDS patients in southern Thailand. Parasitol Res. 2006;98(6):588-592.
Tona L, Kambu K, Ngimbi N, Cimanga K, Vlietinck AJ. Antiamoebic and phytochemical screening of some congolese medicinal plants. J Ethnopharmacol. 1998;61(1):57-65.
Kirana C, Record IR, McIntosh GH, Jones GP. Screening for antitumor activity of 11 species of Indonesian Zingiberaceae using human MCF-7 and HT-29 cancer cells. Pharm Biol. 2003;41(4):271-276.
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26(9/10):1231-1237.
Xie J, Schaich KM. Re-evaluation of the 2,2-diphenyl-1-picrylhydrazyl free radical (DPPH) assay for antioxidant activity. J Agric Food Chem. 2014;62(19): 4251-4260.
Tyrakowska B, Soffers AE, Szymusiak H, Boeren S, Boersma MG, Lemanska K, et al. TEAC antioxidant activity of 4-hydroxybenzoates. Free Radic Biol Med. 1999;27(11-12):1427-1436.
Ainsworth EA, Gillespie KM. Estimation of total phenolic content and other oxidation substrates in plant tissues using folin-ciocalteu reagent. Nat Protoc. 2007;2(4):875-877.
Zhishen J, Mengcheng T, Jianming W. The determination of flavonoid contents in mulberry and their scavenging effects on superoxide radicals. Food Chem. 1999;64(4):555-559.
Rattanasinganchan P, Leelawat K, Treepongkaruna SA, Tocharoentanaphol C, Subwongcharoen S, Suthiphongchai T, Tohtong R. Establishment and characterization of a cholangiocarcinoma cell line (RMCCA-1) from a Thai patient. World J Gastroenterol. 2006;12(40):6500-6506.
Rabou AA, Ahmed HH. Bevacizumab and CCR2 inhibitor nanoparticles induce cytotoxicity-mediated apoptosis in doxorubicin-treated hepatic and non-small lung cancer cells. Asian Pac J Cancer Prev. 2019;20(7):2225-2238.
Dasari S, Tchounwou PB. Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;5(740):364-378.
Rauha JP, Remes S, Heinonen M, Hopia A, Kahkonen M, Kujala T, et al. Antimicrobial effects of finnish plant extracts containing flavonoids and other phenolic compounds. Int. J. Food Microbiol. 2000;56(1):3-12.
Weinstein MP, editor. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 11th ed. Wayne, PA. United states: Clinical and Laboratory Standards Institute; 2013.
Krishan A, Arya P. Monitoring of cellular resistance to cancer chemotherapy. Hematol Oncol Clin North Am. 2002;16(2):357-372.
Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol. 2005;16 Suppl 2:ii93-96.
Vivas R, Barbosa AT, Dolabela SS, Jain S. Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview. Microbial Drug Resistance. 2019;25(6):890-908.